oxotremorine m has been researched along with solifenacin succinate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, T; Kawashima, K | 1 |
1 other study(ies) available for oxotremorine m and solifenacin succinate
Article | Year |
---|---|
YM905, a novel M3 antagonist, inhibits Ca2+ signaling and c-fos gene expression mediated via muscarinic receptors in human T cells.
Topics: Calcium Signaling; Cells, Cultured; Genes, fos; Humans; Isoquinolines; Muscarinic Antagonists; Oxotremorine; Quinuclidines; Receptor, Muscarinic M3; Receptors, Muscarinic; RNA, Messenger; Solifenacin Succinate; T-Lymphocytes; Tetrahydroisoquinolines | 2000 |